Article (Published version) (263 Kb) - Limited access to UNIGE
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C.
|Published in||Liver International. 2013, vol. 33, no. 1, p. 94-103|
|Abstract||Antiviral treatment of chronic hepatitis C is not invariably successful, costly and associated with serious side-effects, and therefore should be indicated only when the chances of benefitting patients exceed the potential risks. The suppressor of cytokine signalling (SOCS) family members have been suggested to affect the rate of virological response to therapy, but the published evidence is conflicting.|
|Research groups||Etudes et traitement de l'hépatite C et B (554)|
Métastases du foie (657)
|PASCARELLA ROCHAT, Stéphanie et al. Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C. In: Liver International, 2013, vol. 33, n° 1, p. 94-103. doi: 10.1111/liv.12031 https://archive-ouverte.unige.ch/unige:27533|